Vivos Therapeutics, Inc.
VVOS
$2.14
$0.010.47%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.34M | 6.26M | 6.31M | 6.90M | 2.61M |
| Total Receivables | 718.00K | 430.00K | 454.00K | 395.00K | 525.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 547.00K | 783.00K | 634.00K | 554.00K | 475.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 3.61M | 7.47M | 7.40M | 7.85M | 3.61M |
|
|
|||||
| Total Current Assets | 3.61M | 7.47M | 7.40M | 7.85M | 3.61M |
| Net Property, Plant & Equipment | 4.26M | 4.38M | 4.45M | 4.48M | 4.63M |
| Long-term Investments | 2.84M | 2.84M | 2.84M | 2.84M | 2.84M |
| Goodwill | 2.84M | 2.84M | 2.84M | 2.84M | 2.84M |
| Total Other Intangibles | 358.00K | 370.00K | 383.00K | 395.00K | 408.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 215.00K | 216.00K | 276.00K | 276.00K | 308.00K |
| Total Assets | 11.28M | 15.28M | 15.35M | 15.84M | 11.80M |
|
|
|||||
| Total Accounts Payable | 1.21M | 1.10M | 1.08M | 2.03M | 2.50M |
| Total Accrued Expenses | 1.78M | 2.23M | 2.05M | 2.19M | 2.47M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 467.00K | 477.00K | 485.00K | 484.00K | 483.00K |
| Total Finance Division Other Current Liabilities | 1.24M | 1.17M | 1.51M | 1.95M | 2.62M |
| Total Other Current Liabilities | 1.24M | 1.17M | 1.51M | 1.95M | 2.62M |
| Total Current Liabilities | 4.70M | 4.98M | 5.13M | 6.64M | 8.07M |
|
|
|||||
| Total Current Liabilities | 4.70M | 4.98M | 5.13M | 6.64M | 8.07M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 932.00K | 1.04M | 1.16M | 1.28M | 1.40M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.24M | 1.32M | 1.40M | 1.57M | 1.75M |
| Total Liabilities | 6.88M | 7.33M | 7.68M | 9.50M | 11.22M |
|
|
|||||
| Common Stock & APIC | 112.46M | 112.14M | 109.03M | 105.09M | 97.40M |
| Retained Earnings | -108.05M | -104.19M | -101.36M | -98.74M | -96.81M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 4.41M | 7.95M | 7.67M | 6.35M | 582.00K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.41M | 7.95M | 7.67M | 6.35M | 582.00K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.41M | 7.95M | 7.67M | 6.35M | 582.00K |
|
|
|||||